Texas § 1379.051 ROUTINE PATIENT CARE COSTS.

Texas Statutes

§ 1379.051 — ROUTINE PATIENT CARE COSTS.

Texas § 1379.051

Code INInsurance Code

This text of Texas § 1379.051 (ROUTINE PATIENT CARE COSTS.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Insurance Code Code Ann. § 1379.051 (2026).

Text

Sec. 1379.051. ROUTINE PATIENT CARE COSTS. For purposes of this chapter, routine patient care costs means the costs of any medically necessary health care service for which benefits are provided under a health benefit plan, without regard to whether the enrollee is participating in a clinical trial. Routine patient care costs do not include:

(1)the cost of an investigational new drug or device that is not approved for any indication by the United States Food and Drug Administration, including a drug or device that is the subject of the clinical trial;

(2)the cost of a service that is not a health care service, regardless of whether the service is required in connection with participation in a clinical trial;

(3)the cost of a service that is clearly inconsistent with widely accepted and

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 1379.051. ROUTINE PATIENT CARE COSTS. For purposes of this chapter, routine patient care costs means the costs of any medically necessary health care service for which benefits are provided under a health benefit plan, without regard to whether the enrollee is participating in a clinical trial. Routine patient care costs do not include:
(1) the cost of an investigational new drug or device that is not approved for any indication by the United States Food and Drug Administration, including a drug or device that is the subject of the clinical trial;
(2) the cost of a service that is not a health care service, regardless of whether the service is required in connection with participation in a clinical trial;
(3) the cost of a service that is clearly inconsistent with widely accepted and established standards of care for a particular diagnosis;
(4) a cost associated with managing a clinical trial; or
(5) the cost of a health care service that is specifically excluded from coverage under a health benefit plan.